Abstract | BACKGROUND:
Giant cell granuloma is rare in the head and neck region and most commonly affects the maxilla and mandible. Although it is a benign disease process, it may be locally destructive. Surgery is the treatment currently recommended. Because of the location of the disease, surgery may be disfiguring. Because it is a benign process, less radical nonsurgical treatment alternatives are desirable. METHODS: RESULTS: After six weekly intralesional steroid injections, a giant cell granuloma of the maxilla became calcified and smaller. After a follow-up period of 2 years, there was no evidence of regrowth, and the bony osteolytic lesion had filled with bone. A review of the literature revealed two case reports of successful steroid injections with similar response. CONCLUSIONS:
|
Authors | A Khafif, G Krempl, J E Medina |
Journal | Head & neck
(Head Neck)
Vol. 22
Issue 8
Pg. 822-5
(Dec 2000)
ISSN: 1043-3074 [Print] United States |
PMID | 11084644
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Glucocorticoids
- Triamcinolone
- Bupivacaine
|
Topics |
- Adult
- Bupivacaine
(administration & dosage)
- Female
- Follow-Up Studies
- Glucocorticoids
(administration & dosage)
- Granuloma, Giant Cell
(diagnosis, drug therapy)
- Humans
- Injections, Intralesional
- Maxillary Neoplasms
(diagnosis, drug therapy)
- Tomography, X-Ray Computed
- Treatment Outcome
- Triamcinolone
(administration & dosage)
|